Dyadic to Present at World Vaccine Congress Washington 2023
JUPITER, Fla., March 30, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
News
MedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial Results
PHOENIX, March 30, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the…
MedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial Results
PHOENIX, March 30, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the…
Inventiva announces filing of its 2022 Universal Registration Document and 2022 Annual Report on Form 20-F
Daix (France), Long Island City (New York, United States), March 30, 2023 Inventiva (Euronext Paris…
Inventiva announces filing of its 2022 Universal Registration Document and 2022 Annual Report on Form 20-F
Daix (France), Long Island City (New York, United States), March 30, 2023 Inventiva (Euronext Paris…
IMUNON Reports 2022 Financial Results and Provides Business Update
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., March 30, 2023 (GLOBE…
Rumi Scientific Appoints Allen A. Fienberg, Ph.D., as Chief Executive Officer and Chairman of the Board of Directors
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) — Rumi Scientific (“Rumi”), a developer of therapies…
Achieve Life Sciences Announces Refresh to Board of Directors
SEATTLE, Wash. and VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences,…
Theriva Biologics Reports Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results
– Dosed the first patient in VIRAGE, a Phase 2b clinical trial of systemically administered…
DataStax Again Achieves Best Place to Work Distinction Fueled by Exceptional Employee Satisfaction and Positive Culture
DataStax Honored with Six New Workplace Awards from Comparably: Best Company Outlook, Best Company to…
PDS Biotech Announces Plan to Initiate Phase 3 Study Evaluating PDS0101 in Combination with KEYTRUDA® in Head and Neck Cancer in 2023
Company has completed Phase 3 manufacturing of PDS0101 for randomized, controlled, registrational trial in recurrent/metastatic…
Candel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Highlights
Expects to announce clinical trial data from multiple oncology programs in the second half of…
Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer
Media Release Expanding INSIGHT-003 trial evaluating efti with standard-of-care combination of anti-PD-1 therapy and chemotherapy…
Avalyn Pharma Reports Results of Phase 1 Study of AP02 in Healthy Volunteers and Participants with Idiopathic Pulmonary Fibrosis
Seattle, March 30, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused…
Verizon continues to upgrade Grand Rapids’ best network
Recent upgrades lead to testing results that show Verizon’s network is unbeaten in Grand Rapids…
Verizon drives appx. $700 million in cost savings for Dept. of Health and Human Services over the life of the EIS contract
Recent EIS task order enables HHS to consolidate network technology modernization efforts into a single…
Pushpay Announces New Product Innovations to Help Streamline Ministry Operations and Increase Engagement in the Church
REDMOND, Wash., March 30, 2023 (GLOBE NEWSWIRE) — Pushpay (NZSX:PPH, ASX:PPH, ‘Pushpay’ or ‘the Company’),…
Virtru Announces First Ever FIPS 140-2 Validated JavaScript Cryptographic Module
Virtru brings FIPS 140-2 validated cryptography natively into the browser runtime environment WASHINGTON, March 30,…
Sekur Private Data Ltd. Launches 2FA Identity Security Feature for its Swiss Hosted Sekur Solutions for Businesses and Consumers
Toronto, Ontario, and New York, New York–(Newsfile Corp. – March 30, 2023) – Sekur Private…
Marble Financial Announces Bond Debt Restructuring to Strengthen Balance Sheet
Proposed restructuring of up to $5.766 million of debt. Vancouver, British Columbia–(Newsfile Corp. – March…